EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 3.0

Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects

Mengli Tian, Jinlong Huang, Yingrong Chen, Qiuyue Jin, Hong Jiang, Cunyuan Shi, Jue Mei, Min Xu, Xiang Yu, Shuixin Yang

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s485851 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Mengli Tian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, 313000, People's Re…. Hauptthemen laut MEDLINE: Amlodipine, Amlodipine, Valsartan Drug Combination, Valsartan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmlodipineAmlodipine, Valsartan Drug CombinationValsartanAdultFemaleHumansMaleYoung AdultAdministration, OralChromatography, High Pressure LiquidCross-Over StudiesEast Asian PeopleHealthy VolunteersTabletsTandem Mass SpectrometryTherapeutic Equivalency

Stichwörter der Autor:innen

amlodipinebioequivalencepharmacokineticssafetyvalsartan

Substanzen

AmlodipineAmlodipine, Valsartan Drug CombinationTabletsValsartan

Autor:innen und Institutionen

  • Clinical Trial Center, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, 313000, People's Republic of China.
  • Zhejiang Jianfeng Pharmaceutical Co Ltd., Jinhua, 321025, People's Republic of China.

Zitieren

APA

Tian, M., Huang, J., Chen, Y., Jin, Q., Jiang, H., Shi, C., Mei, J., Xu, M., Yu, X., & Yang, S. (2025). Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s485851

Vancouver

Tian M, Huang J, Chen Y, Jin Q, Jiang H, Shi C, et al. Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s485851

BibTeX
@article{Tian2025,
  author = {Tian, Mengli and Huang, Jinlong and Chen, Yingrong and Jin, Qiuyue and Jiang, Hong and Shi, Cunyuan and Mei, Jue and Xu, Min and Yu, Xiang and Yang, Shuixin},
  title = {Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s485851}
}
Kostenlos starten →